Depression affects people differently, and some adults may not respond adequately to traditional antidepressants. This is known as treatment-resistant depression (TRD). One treatment option that may be considered is SPRAVATO® (esketamine) nasal spray.
What Is SPRAVATO®?
SPRAVATO® is an FDA-approved prescription medication containing esketamine. It works differently from many traditional antidepressants and requires an individual evaluation by a qualified healthcare professional.
At Valcourt, Spravato treatment is administered by certified psychiatrists in a clinical setting designed for the monitoring and support this medication requires. Our team evaluates each case individually to determine whether this or other treatment options fit your needs. Our business hours are Monday Thru Saturdays from 9:00 am to 5:00 pm.
We accept all major insurances, have after work hours, onsite and online services. 📞 305-764-0194
How Is Treatment Administered?
SPRAVATO® is administered as a nasal spray under professional supervision at a certified treatment center. Patients are monitored for at least two hours after treatment due to possible effects such as sedation, dissociation, dizziness, nausea, and temporary increases in blood pressure.
SPRAVATO® is available through the FDA-required SPRAVATO® REMS Program.
Who May Be Considered?
A healthcare professional evaluates medical history, previous treatments, current medications, and potential risks and benefits to determine whether SPRAVATO® may be appropriate.
Important Notice
This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Treatment options and results vary by individual.
